New insider activity at Patterson-UTI ( (PTEN) ) has taken place on March 18, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Director Robert Wayne Drummond has executed a notable insider sale of Patterson-UTI stock, disposing of 164,775 shares in a transaction valued at $1,677,409. This sizable move by a board member may draw investor attention as markets assess what the sale could signal about sentiment toward Patterson-UTI’s current valuation and future prospects.
Recent Updates on PTEN stock
Patterson-UTI shares saw positive sentiment as Goldman Sachs lifted its outlook, citing that while current geopolitical risks may create short-term volatility, emerging market dislocations could offer attractive entry points versus underlying fundamentals. The firm also believes long-term customer activity should remain intact, as much of the anticipated growth is driven by structural needs to offset natural production declines and expand capacity rather than transient factors.
Spark’s Take on PTEN Stock
According to Spark, TipRanks’ AI Analyst, PTEN is a Neutral.
PTEN scores mid-range primarily due to strong operating/free cash flow and a supportive earnings-call outlook focused on disciplined CapEx and higher shareholder returns, partially offset by volatile/negative net profitability and a notable 2025 revenue decline. Technically the stock is in a strong uptrend, but overbought momentum signals reduce the near-term technical score, while valuation is mixed due to a negative P/E despite an attractive dividend yield.
To see Spark’s full report on PTEN stock, click here.
More about Patterson-UTI
YTD Price Performance: 77.48%
Average Trading Volume: 10,921,020
Technical Sentiment Signal: Buy
Current Market Cap: $4.07B